Hutchison MediPharma Ltd - Product Pipeline Review

Global Markets Direct’s, ‘Hutchison MediPharma Ltd - Product Pipeline Review - 2016’, provides an overview of the Hutchison MediPharma Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Hutchison MediPharma Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Hutchison MediPharma Ltd

The report provides overview of Hutchison MediPharma Ltd including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Hutchison MediPharma Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Hutchison MediPharma Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Hutchison MediPharma Ltd’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Hutchison MediPharma Ltd

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Hutchison MediPharma Ltd’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hutchison MediPharma ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hutchison MediPharma Ltd Snapshot 6

Hutchison MediPharma Ltd Overview 6

Key Facts 6

Hutchison MediPharma Ltd - Research and Development Overview 7

Key Therapeutic Areas 7

Hutchison MediPharma Ltd - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Hutchison MediPharma Ltd - Pipeline Products Glance 12

Hutchison MediPharma Ltd - Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Hutchison MediPharma Ltd - Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Hutchison MediPharma Ltd - Early Stage Pipeline Products 15

IND/CTA Filed Products/Combination Treatment Modalities 15

Preclinical Products/Combination Treatment Modalities 16

Hutchison MediPharma Ltd - Drug Profiles 17

HMPL-012 - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

HMPL-013 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

HMPL-309 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

HMPL-453 - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

HMPL-507 - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

HMPL-518 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

HMPL-523 - Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

HMPL-689 - Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

HMPL-813 - Drug Profile 33

Product Description 33

Mechanism Of Action 33

R&D Progress 33

savolitinib - Drug Profile 35

Product Description 35

Mechanism Of Action 35

R&D Progress 35

Hutchison MediPharma Ltd - Pipeline Analysis 40

Hutchison MediPharma Ltd - Pipeline Products by Target 40

Hutchison MediPharma Ltd - Pipeline Products by Route of Administration 42

Hutchison MediPharma Ltd - Pipeline Products by Molecule Type 43

Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action 44

Hutchison MediPharma Ltd - Dormant Projects 46

Hutchison MediPharma Ltd - Locations And Subsidiaries 47

Head Office 47

Other Locations & Subsidiaries 47

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

List of Tables

Hutchison MediPharma Ltd, Key Facts 6

Hutchison MediPharma Ltd - Pipeline by Indication, 2016 8

Hutchison MediPharma Ltd - Pipeline by Stage ...

List of Tables

Hutchison MediPharma Ltd, Key Facts 6

Hutchison MediPharma Ltd - Pipeline by Indication, 2016 8

Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016 10

Hutchison MediPharma Ltd - Monotherapy Products in Pipeline, 2016 11

Hutchison MediPharma Ltd - Phase III, 2016 12

Hutchison MediPharma Ltd - Phase II, 2016 13

Hutchison MediPharma Ltd - Phase I, 2016 14

Hutchison MediPharma Ltd - IND/CTA Filed, 2016 15

Hutchison MediPharma Ltd - Preclinical, 2016 16

Hutchison MediPharma Ltd - Pipeline by Target, 2016 41

Hutchison MediPharma Ltd - Pipeline by Route of Administration, 2016 42

Hutchison MediPharma Ltd - Pipeline by Molecule Type, 2016 43

Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action, 2016 45

Hutchison MediPharma Ltd - Dormant Developmental Projects,2016 46

Hutchison MediPharma Ltd, Other Locations 47

List of Figures

List of Figures

Hutchison MediPharma Ltd - Pipeline by Top 10 Indication, 2016 8

Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016 10 ...

List of Figures

Hutchison MediPharma Ltd - Pipeline by Top 10 Indication, 2016 8

Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016 10

Hutchison MediPharma Ltd - Monotherapy Products in Pipeline, 2016 11

Hutchison MediPharma Ltd - Pipeline by Top 10 Target, 2016 40

Hutchison MediPharma Ltd - Pipeline by Route of Administration, 2016 42

Hutchison MediPharma Ltd - Pipeline by Molecule Type, 2016 43

Hutchison MediPharma Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016 44

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports